These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 9647740)
61. Comprehensive Endogenous Tagging of Basement Membrane Components Reveals Dynamic Movement within the Matrix Scaffolding. Keeley DP; Hastie E; Jayadev R; Kelley LC; Chi Q; Payne SG; Jeger JL; Hoffman BD; Sherwood DR Dev Cell; 2020 Jul; 54(1):60-74.e7. PubMed ID: 32585132 [TBL] [Abstract][Full Text] [Related]
62. Expression of laminin-2 by normal and neoplastic rat C cells during the development of medullary thyroid carcinoma. Lekmine F; Feracci H; Milhaud G; Treilhou-Lahille F; Jeanne N Virchows Arch; 1999 Apr; 434(4):325-32. PubMed ID: 10335943 [TBL] [Abstract][Full Text] [Related]
63. Overexpression of tissue inhibitor of metalloproteinases-2 retroviral-mediated gene transfer in vivo inhibits tumor growth and invasion. Imren S; Kohn DB; Shimada H; Blavier L; DeClerck YA Cancer Res; 1996 Jul; 56(13):2891-5. PubMed ID: 8674034 [TBL] [Abstract][Full Text] [Related]
64. Establishing laminin, collagen IV and chondroitin sulfate patterns in otocystogenesis. Callejo S; Barbosa M; Moro JA; Gato A; Alonso MI; Barbosa E Int J Dev Biol; 1996; Suppl 1():249S-250S. PubMed ID: 9087783 [No Abstract] [Full Text] [Related]
65. Glucocorticoids maintain the extracellular matrix of differentiated mammary tissue during explant and whole organ culture. Casey TM; Boecker A; Chiu JF; Plaut K Proc Soc Exp Biol Med; 2000 Jun; 224(2):76-86. PubMed ID: 10806414 [TBL] [Abstract][Full Text] [Related]
66. Histopathological findings in a highly invasive mouse mammary carcinoma transfected with human tissue inhibitor of metalloproteinases-1. Alonso DF; Skilton G; De Lorenzo MS; Scursoni AM; Yoshiji H; Gomez DE Oncol Rep; 1998; 5(5):1083-7. PubMed ID: 9683813 [TBL] [Abstract][Full Text] [Related]
67. Hypoxia-induced upregulation of matrix metalloproteinase 9 increases basement membrane degradation by downregulating collagen type IV alpha 1 chain. Zhu MM; Ma Y; Tang M; Pan L; Liu WL Physiol Res; 2022 Dec; 71(6):825-834. PubMed ID: 36281728 [TBL] [Abstract][Full Text] [Related]
68. Complete suppression of tumor formation by high levels of basement membrane collagen. Harris A; Harris H; Hollingsworth MA Mol Cancer Res; 2007 Dec; 5(12):1241-5. PubMed ID: 18171981 [TBL] [Abstract][Full Text] [Related]
69. Tissue inhibitor of metalloprotease (TIMP)-1 and proliferative behaviour of clonal breast cancer cells. Luparello C; Avanzato G; Carella C; Pucci-Minafra I Breast Cancer Res Treat; 1999 Apr; 54(3):235-44. PubMed ID: 10445422 [TBL] [Abstract][Full Text] [Related]
70. Effects of Experimental Hyperthyroidism on Collagen IV and Laminin-α5 Gene Expression in Balb/C Mouse Seminiferous Tubules. Sadeghi S; Jalali M; Nikravesh MR; Sankian M Galen Med J; 2019; 8():e1369. PubMed ID: 34466503 [TBL] [Abstract][Full Text] [Related]
71. Microarray-based analysis for hepatocellular carcinoma: from gene expression profiling to new challenges. Midorikawa Y; Makuuchi M; Tang W; Aburatani H World J Gastroenterol; 2007 Mar; 13(10):1487-92. PubMed ID: 17461438 [TBL] [Abstract][Full Text] [Related]
72. Basement membrane remodeling in skeletal muscles of patients with limb ischemia involves regulation of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases. Baum O; Ganster M; Baumgartner I; Nieselt K; Djonov V J Vasc Res; 2007; 44(3):202-13. PubMed ID: 17337906 [TBL] [Abstract][Full Text] [Related]
76. Stimulatory effect of endogenous tissue inhibitor of metalloproteinases-1 (TIMP-1) overexpression on type IV collagen and laminin gene expression in rat mammary carcinoma cells. Yoshiji H; Buck TB; Harris SR; Ritter LM; Lindsay CK; Thorgeirsson UP Biochem Biophys Res Commun; 1998 Jun; 247(3):605-9. PubMed ID: 9647740 [TBL] [Abstract][Full Text] [Related]
77. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary. Sakata K; Shigemasa K; Nagai N; Ohama K Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877 [TBL] [Abstract][Full Text] [Related]